Chong Kun Dang Pharmaceutical Corp. - Company Profile

Powered by

All the data and insights you need on Chong Kun Dang Pharmaceutical Corp. in one report.

$395 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Chong Kun Dang Pharmaceutical Corp. Strategy Report

  • Understand Chong Kun Dang Pharmaceutical Corp. position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Chong Kun Dang Pharmaceutical Corp.: Overview

Select Item

Related keylists

Chong Kun Dang Pharmaceutical Corp (CKD Pharma), manufactures, distributes, imports and exports prescription drugs, OTC drugs, health supplements and consumer health products. The company works following therapeutic areas such as oncology, neurology and immunology and others. Its product portfolio includes prescription products for the entire segment and therapeutic classes; vitamins; shampoos; hair colours; aerosols; mat vaporizers and mosquito coils; and others. The company’s Chong Kun Dang Research Institute is characterized by three independent laboratories, namely, The New Drug Discovery Labs, The Technology Development Labs; and the Bio Research Labs. It has a manufacturing facility in Cheonan City, South Korea. CKD Pharma is headquartered in Seoul, South Korea.

 Gain a 360-degree view of Chong Kun Dang Pharmaceutical Corp. and make more informed decisions for your business Gain a 360-degree view of Chong Kun Dang Pharmaceutical Corp. and make more informed decisions for your business Find out more
Headquarters South Korea
Address 8, Chungjeong-Ro, Seodaemun-Gu, Seoul, 03742
Website www.ckdpharm.com
Telephone 82 2 21940300
No of Employees 1,904
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange 185750 (KRX)
Revenue (2022) $1.3B 12.2% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ 162.5% (2022 vs 2021)
Market Cap* $1.0B
Net Profit Margin (2022) XYZ 134.0% (2022 vs 2021)
* As of and is in US$
View Chong Kun Dang Pharmaceutical Corp. financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Chong Kun Dang Pharmaceutical Corp. premium industry data and analytics

360+

Clinical Trials

Determine Chong Kun Dang Pharmaceutical Corp. go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

340+

Marketed Drugs

Understand Chong Kun Dang Pharmaceutical Corp.’s commercialized product portfolio to stay one step ahead of the market.

150+

Catalyst Calendar

Proactively evaluate Chong Kun Dang Pharmaceutical Corp.’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

110+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Chong Kun Dang Pharmaceutical Corp.’s relevant decision makers and contact details.

80+

Pipeline Drugs

Identify which of Chong Kun Dang Pharmaceutical Corp.’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

10+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

2

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Chong Kun Dang Pharmaceutical Corp.’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
- Liquistal
Prescription Drugs Duvie
Over the Counter Products Camptobell
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Chong Kun Dang Pharmaceutical Corp. portfolio and identify potential areas for collaboration Understand Chong Kun Dang Pharmaceutical Corp. portfolio and identify potential areas for collaboration Find out more
Image for loader

Competitor Comparison

Key Parameters Chong Kun Dang Pharmaceutical Corp. Daewoong Pharmaceutical Co Ltd Dong-A Socio Holdings Co Ltd Ildong Pharmaceutical Co Ltd Suheung Capsule Co Ltd
Headquarters South Korea South Korea South Korea South Korea South Korea
City Seoul Hwaseong Seoul Seoul Cheongju
No. of Employees 1,904 1,256 273 1,433 727
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Young-Joo Kim President; Chief Executive Officer Senior Management 2021 -
Kim Seong-gon Director Non Executive Board - -
Kang In-Soo Director Non Executive Board 2019 -
Chang Dong-shin Director Non Executive Board 2022 -
Lim Jong-Rae Director Non Executive Board - -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Chong Kun Dang Pharmaceutical Corp. key executives to enhance your sales strategy Gain insight into Chong Kun Dang Pharmaceutical Corp. key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward